Elder okays restructuring plan amid mounting part-sale speculation
This article was originally published in Scrip
Executive Summary
The board of Elder Pharmaceuticals has approved plans for a revamp of the company's business including by way of raising capital or a hive off of assets, amid heightened speculation that the company may be inching closer to a potential sale of some part of its business.